NOVEL STRATEGIES (FKA) PRISM GROUP

Lobbying for THE ALLIANCE FOR LONGEVITY INITIATIVES · Advancing policies to increase a healthy human lifespan.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Virginia · House · Senate · $20,000.00 income · posted Apr 17, 2026

Lobbying activity 2

Health Issues

Directing the Food and Drug Administration to create a pathway for longevity treatment. Reauthorization of the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs at the National Institutes of Health.

Budget/Appropriations

Increased funding for longevity research at the National Institutes of Health

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.